Rapid distribution of liposomal short-chain ceramide in vitro and in vivo
- PMID: 18490436
- DOI: 10.1124/dmd.107.019679
Rapid distribution of liposomal short-chain ceramide in vitro and in vivo
Abstract
Ceramide, an endogenous sphingolipid, has demonstrated antieoplastic activity in vitro and in vivo. However, the chemotherapeutic utility of ceramide is limited because of its insolubility. To increase the solubility of ceramide, liposomal delivery systems have been used. The objective of the present study was to characterize the pharmacokinetics and tissue distribution of C6-ceramide and control (non-C6-ceramide) nanoliposomes in rats, using [14C]C6-ceramide and [3H]distearylphosphatidylcholine (DSPC) as tracers of the ceramide and liposome components, respectively. Ceramide liposomes were administered at 50 mg of liposomes/kg by jugular vein to female Sprague-Dawley rats. The apparent volume of distribution (Vd) of [3H]DSPC was approximately 50 ml/kg, suggesting that the liposomes were confined to the systemic circulation. In contrast, the Vd of [14C]C6-ceramide was 20-fold greater than that of liposomes, indicating extensive tissue distribution. This high Vd of [14C]C6-ceramide in relation to that of [3H]DSPC suggests that ceramide and liposomes distribute independently of each other. This disparate disposition was confirmed by tissue distribution studies, in which [14C]C6-ceramide exhibited rapid tissue accumulation compared with to [3H]DSPC. Examination of ceramide liposome blood compartmentalization in vitro also demonstrated divergent partitioning, with liposomes being confined to the plasma fraction and ceramide rapidly equilibrating between red blood cell and plasma fractions. A bilayer exchange mechanism for ceramide transfer is proposed to explain the results of the present study, as well as give insight into the documented antineoplastic efficacy of short-chain ceramide liposomes. Our studies suggest that this nanoscale PEGylated drug delivery system for short-chain ceramide offers rapid tissue distribution without adverse effects for a neoplastic-selective, insoluble agent.
Similar articles
-
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.Clin Cancer Res. 2005 May 1;11(9):3465-74. doi: 10.1158/1078-0432.CCR-04-1770. Clin Cancer Res. 2005. PMID: 15867249
-
Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.J Pharmacol Exp Ther. 2003 Nov;307(2):468-75. doi: 10.1124/jpet.103.054056. Epub 2003 Sep 15. J Pharmacol Exp Ther. 2003. PMID: 12975495
-
PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.Pharm Res. 2014 Mar;31(3):684-93. doi: 10.1007/s11095-013-1190-5. Epub 2013 Sep 25. Pharm Res. 2014. PMID: 24065591 Free PMC article.
-
Fate and behavior of liposomes in vivo: a review of controlling factors.Crit Rev Ther Drug Carrier Syst. 1987;3(2):123-93. Crit Rev Ther Drug Carrier Syst. 1987. PMID: 3542245 Review.
-
Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic.Biol Chem. 2015 Jun;396(6-7):737-47. doi: 10.1515/hsz-2015-0129. Biol Chem. 2015. PMID: 25838296 Review.
Cited by
-
Conjugation of peptides to short-acyl-chain ceramides for delivery across mucosal cell barriers.Bioorg Med Chem Lett. 2020 Apr 15;30(8):127014. doi: 10.1016/j.bmcl.2020.127014. Epub 2020 Feb 7. Bioorg Med Chem Lett. 2020. PMID: 32081448 Free PMC article.
-
Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.Integr Biol (Camb). 2013 Jan;5(1):66-73. doi: 10.1039/c2ib20117h. Integr Biol (Camb). 2013. PMID: 22772974 Free PMC article.
-
The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway.Cancers (Basel). 2021 Jun 18;13(12):3052. doi: 10.3390/cancers13123052. Cancers (Basel). 2021. PMID: 34207464 Free PMC article.
-
Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models.Cancer Lett. 2013 Sep 1;337(2):254-65. doi: 10.1016/j.canlet.2013.04.034. Epub 2013 May 7. Cancer Lett. 2013. PMID: 23664889 Free PMC article.
-
Stable isotope method to measure drug release from nanomedicines.J Control Release. 2015 Dec 28;220(Pt A):169-174. doi: 10.1016/j.jconrel.2015.10.042. Epub 2015 Oct 24. J Control Release. 2015. PMID: 26596375 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources